Literatuur Aman, M.G., Arnold, L.E., McDougle, C.J., Vitiello, B., Scahill, L., Davies, M., McCracken, J.T. et al. 2005. Acute and long-term safety and tolerability of risperidone in children with autism. J Child Adolesc Psychopharmacol. 15:869-84. Arnold, L.E., Vitiello, B., McDougle, C., Scahill, L., Shah, B., Gonzalez, N.M., Chuang, S., Davies, M. et al 2003. Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials. J Am Acad Child Adolesc Psychiatry. 42:1443-50. Belsito, K.M., Law, P.A., Kirk, K.S., Landa, R.J., Zimmerman, A.W. (2001). Lamotrigine therapy for autistic disorder: a randomized, double-blind, placebocontrolled trial. J Autism Dev Disord. 31:175-81. Buitelaar, J.K. & Willemsen-Swinkels, S.H.N. (2000) Medication treatment in subjects with autistic spectrum disorders. Eur Child Adolesc Psychiat 9:I85-I97. Buitelaar, J.K., van der Gaag, R.J., Van der Hoeven, J., (1998) Buspirone in the management of anxiety and irritability in children with pervasive developmental disorders: results of an open-label study. J Clin Psychiatry. 59:56-9. Campbell, M., Armenteros, J.L., Malone, R.P., Adams, P.B., Eisenberg, Z.W., Overall, J.W. (1997). Neuroleptic-related dyskinesias in autistic children: a prospective, longitudinal study. J Am Acad Child Adolesc Psychiatry. 36:835-43. Campbell, M., Anderson, L.T., Small, A.M., Perry, R., Green, W.H., Caplan, R. (1982). The effects of haloperidol on learning and behavior in autistic children. J Autism Dev Disord. 12:167-75. Chez, M.G., Buchanan, C.P., Aimonovitch, M.C., Becker, M., Schaefer, K., Black, C., Komen, J. (2002). Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders. J Child Neurol.17:833-7. Fankhauser, M.P., Karumanchi, V.C., German, M.L. Yates, A., Karumanchi, S.D. (1992) A double-blind, placebo controlled study of the efficacy of transdermal clonidine in autism. J Clin Psychiat 53: 77-82. Handen, B.L., Johnson, C.R., Lubetsky, M. (2000) Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder. J Autism Dev Disord. 30:245-55. Hellings, J.A., Weckbaugh, M., Nickel, E.J., Cain, S.E., Zarcone, J.R., Reese, R.M., Hall, S., et al. (2005). A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders. J Child Adolesc Psychopharmacol. 15:682-92. Hollander, E., Phillips, A., Chaplin, W., Zagursky, K., Novotny, S., Wasserman, S., Iyengar, R. (2005). A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology. 30:582-9. Hollander, E., Soorya, L., Wasserman, S., Esposito, K., Chaplin, W., Anagnostou, E. (2006). Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder. Int J Neuropsychopharmacol. 9:209-13. Jaselskis, C., Cook, E.H., Fletcher, K.E., Leventhal, B. (1992). Clonidine treatment of hyperactive and impulsive children with autistic disorder. J Clin. Psychopharmacology 12:322-327. Jou, R.J., Handen, B.L., Hardan, A.Y. (2005) Retrospective assessment of atomoxetine in children and adolescents with pervasive developmental disorders. J Child Adolesc Psychopharmacol. 15:325-30. King, B.H., Wright, D.M., Handen, B.L., Sikich, L., Zimmerman, A.W., McMahon, W., Cantwell, E. et al. (2001). Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder. J Am Acad Child Adolesc Psychiatry. 40:658-65. Kolevzon, A., Mathewson, K.A., Hollander, E. (2006) Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability. J Clin Psychiatry. 67:407-14. McCracken, J.T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M.G., Arnold, L.E. et al. (2002) Risperidone in children with autism and serious behavioral problems. N Engl J Med. 347:314-21. advertentie Paavonen, E.J., Nieminen – von Wendt, T., Vanhala, R., Aronen, E.T., von Wendt, L. (2003). Effectiveness of melatonin in the treatment of sleep disturbances in children with Asperger disorder. J Child Adolesc Psychopharmacol. 13:83-95. Quintana, H., Birmaher, B., Stedge, D., Lennon, S., Freed, J., Bridge, J., Greenhill, L. (1995) Use of methylfenidate in the treatment of children with autistic disorder. J Autism Dev Disord. 25:283-294, 1995. Smits, M.G., van Stel, H.F., van der Heijden, K., Meijer, A.M., Coenen, A.M., Kerkhof, G.A. (2003). Melatonin improves health status and sleep in children with idiopathic chronic sleep-onset insomnia: a randomized placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 42:1286-93. Stigler, K,A., Desmond, L.A., Posey, D.J., Wiegand, R.E., McDougle, C.J. (2004) A naturalistic retrospective analysis of psychostimulants in pervasive developmental disorders. J Child Adolesc psychopharmacol. 14:49-56. Troost, P.W. (2006) Pharmacological Treatment in Children with Autism Spectrum Disorders. PhD Thesis, University Medical Center Groningen. 77 nummer 2 • augustus 2006
Bijlage bij artikel <strong>Wetenschappelijk</strong> <strong>Tijdschrift</strong> <strong>Autisme</strong> Dit artikel is verschenen in het <strong>Wetenschappelijk</strong> <strong>Tijdschrift</strong> <strong>Autisme</strong>. Het tijdschrift is online te vinden op www.wetenschappelijktijdschriftautisme.nl. Over het <strong>Wetenschappelijk</strong> <strong>Tijdschrift</strong> <strong>Autisme</strong> Het <strong>Wetenschappelijk</strong> <strong>Tijdschrift</strong> <strong>Autisme</strong> is een uitgave van de NVA, de Nederlandse Vereniging voor <strong>Autisme</strong>. De website van de NVA is www.autisme.nl. Het blad verschijnt 3 keer per jaar. Het verschijnt onder de verantwoordelijkheid van een onafhankelijke redactie. Contact U kunt ons per mail bereiken op: redactie@wetenschappelijktijdschriftautisme.nl De overige contactgegevens vindt u op onze website. Deze pagina is aan de PDF toegevoegd in augustus 2010.